PDS Biotechnology Corp. Announces Board Changes
Ticker: PDSB · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, management, governance
TL;DR
PDS Biotech board shake-up: director out, new one in, officer pay adjustments.
AI Summary
PDS Biotechnology Corporation announced on April 22, 2025, a change in its board of directors. Specifically, the company reported the departure of a director and the election of a new director, along with updates to its compensatory arrangements for certain officers.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future decision-making.
Risk Assessment
Risk Level: medium — Board changes can introduce uncertainty regarding strategic direction and management stability.
Key Numbers
- 001-37568 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-4231384 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PDS Biotechnology Corporation (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Princeton, NJ (location) — Principal Executive Offices
- Edge Therapeutics, Inc. (company) — Former Company Name
FAQ
Who is the departing director and who is the newly elected director?
The filing does not specify the names of the departing or newly elected directors, only that a change occurred.
What specific changes were made to compensatory arrangements for officers?
The filing indicates updates to compensatory arrangements but does not detail the specific changes made.
When did the reported changes to the board of directors become effective?
The changes were reported as of April 22, 2025.
What is the primary business of PDS Biotechnology Corporation?
PDS Biotechnology Corporation is in the Pharmaceutical Preparations industry (SIC code 2834).
Has PDS Biotechnology Corporation changed its name or address recently?
The company was formerly known as Edge Therapeutics, Inc., with a name change date of September 11, 2009. No recent address change is noted in this filing.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding PDS Biotechnology Corp (PDSB).